Review



nootkatone  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress nootkatone
    Fig. 1 NKT inhibited the proliferation and growth of GBM cells in vitro. (A, B) The cell viability of C6 cells and U251 cells treated with gradient concentra tions (0 µM, 100 µM, 200 µM, 300 µM) of <t>nootkatone</t> detected by CCK8 assays (n = 5/group, one-way ANOVA, Tukey’s test was performed for the multiple comparison). (C, E) Cell colony formation of C6 cells and U251 cells treated with DMSO or NKT (200 µM) for approximately 7 days. Scale bar, 500 μm. (D, F) Quantitative analysis of colony number of C6 cells (D) and U251 cells (F) (the surviving colonies > 10 cells) as shown in (C, E) (n = 3/group, t-test). (G, I) Representative images of PH3 staining (red) in C6 cells and U251 cells after being treated with DMSO or 200 µM nootkatone for 48 h. Scale bars, 50 μm. (H, K) Quantitative analysis of the percentages of PH3+ cells over total C6 cells and U251 cells in one field as shown in (G, I) (n = 5/group, t-test). Data were mean ± SEM. *P < 0.05, **P < 0.01
    Nootkatone, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-n2195/Nootkatone/pm39819316-28-0-4
    Average 94 stars, based on 3 article reviews
    nootkatone - by Bioz Stars, 2026-10
    94/100 stars

    Images

    1) Product Images from "Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway."

    Article Title: Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway.

    Journal: Molecular medicine (Cambridge, Mass.)

    doi: 10.1186/s10020-025-01064-1

    Fig. 1 NKT inhibited the proliferation and growth of GBM cells in vitro. (A, B) The cell viability of C6 cells and U251 cells treated with gradient concentra tions (0 µM, 100 µM, 200 µM, 300 µM) of nootkatone detected by CCK8 assays (n = 5/group, one-way ANOVA, Tukey’s test was performed for the multiple comparison). (C, E) Cell colony formation of C6 cells and U251 cells treated with DMSO or NKT (200 µM) for approximately 7 days. Scale bar, 500 μm. (D, F) Quantitative analysis of colony number of C6 cells (D) and U251 cells (F) (the surviving colonies > 10 cells) as shown in (C, E) (n = 3/group, t-test). (G, I) Representative images of PH3 staining (red) in C6 cells and U251 cells after being treated with DMSO or 200 µM nootkatone for 48 h. Scale bars, 50 μm. (H, K) Quantitative analysis of the percentages of PH3+ cells over total C6 cells and U251 cells in one field as shown in (G, I) (n = 5/group, t-test). Data were mean ± SEM. *P < 0.05, **P < 0.01
    Figure Legend Snippet: Fig. 1 NKT inhibited the proliferation and growth of GBM cells in vitro. (A, B) The cell viability of C6 cells and U251 cells treated with gradient concentra tions (0 µM, 100 µM, 200 µM, 300 µM) of nootkatone detected by CCK8 assays (n = 5/group, one-way ANOVA, Tukey’s test was performed for the multiple comparison). (C, E) Cell colony formation of C6 cells and U251 cells treated with DMSO or NKT (200 µM) for approximately 7 days. Scale bar, 500 μm. (D, F) Quantitative analysis of colony number of C6 cells (D) and U251 cells (F) (the surviving colonies > 10 cells) as shown in (C, E) (n = 3/group, t-test). (G, I) Representative images of PH3 staining (red) in C6 cells and U251 cells after being treated with DMSO or 200 µM nootkatone for 48 h. Scale bars, 50 μm. (H, K) Quantitative analysis of the percentages of PH3+ cells over total C6 cells and U251 cells in one field as shown in (G, I) (n = 5/group, t-test). Data were mean ± SEM. *P < 0.05, **P < 0.01

    Techniques Used: In Vitro, Comparison, Staining

    Related Articles

    In Vitro:

    Article Title: Methods, devices and compositions for preserving human milk
    Article Snippet: N3025 MedChemExpress: Indigo carmine 862.5624 MedChemExpress: Triethyl citrate 1099.976 HY-W040226 HY-W011602 MedChemExpress: Acetophenone 1002.631 MedChemExpress: Natamycin 1110.851 HY-Y0989 HY-B0133 MedChemExpress: Quinine 1166.375 MedChemExpress: Bis(2-methyl-3- 1036.712 HY-D0143 HY-W009708 furyl)disulfide MedChemExpress: Nootkatone 1252.835 MedChemExpress: Magnolol 941.9616 HY-N2195 HY-N0163 Me

    Article Title: Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway.
    Article Snippet: Nootkatone was purchased from MedChemExpress (#HY-N2195).. The solid powder was dissolved with DMSO to a concentration of 458.02 mM and stored at -80 °C.The solid powder was dissolved with DMSO to a concentration of 458.02 mM and stored at -80 °C.

    Article Title: Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway
    Article Snippet: Nootkatone was purchased from MedChemExpress (#HY-N2195). .. T

    Comparison:

    Article Title: Methods, devices and compositions for preserving human milk
    Article Snippet: N3025 MedChemExpress: Indigo carmine 862.5624 MedChemExpress: Triethyl citrate 1099.976 HY-W040226 HY-W011602 MedChemExpress: Acetophenone 1002.631 MedChemExpress: Natamycin 1110.851 HY-Y0989 HY-B0133 MedChemExpress: Quinine 1166.375 MedChemExpress: Bis(2-methyl-3- 1036.712 HY-D0143 HY-W009708 furyl)disulfide MedChemExpress: Nootkatone 1252.835 MedChemExpress: Magnolol 941.9616 HY-N2195 HY-N0163 Me

    Article Title: Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway.
    Article Snippet: Nootkatone was purchased from MedChemExpress (#HY-N2195).. The solid powder was dissolved with DMSO to a concentration of 458.02 mM and stored at -80 °C.The solid powder was dissolved with DMSO to a concentration of 458.02 mM and stored at -80 °C.

    Article Title: Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway
    Article Snippet: Nootkatone was purchased from MedChemExpress (#HY-N2195). .. T

    Staining:

    Article Title: Methods, devices and compositions for preserving human milk
    Article Snippet: N3025 MedChemExpress: Indigo carmine 862.5624 MedChemExpress: Triethyl citrate 1099.976 HY-W040226 HY-W011602 MedChemExpress: Acetophenone 1002.631 MedChemExpress: Natamycin 1110.851 HY-Y0989 HY-B0133 MedChemExpress: Quinine 1166.375 MedChemExpress: Bis(2-methyl-3- 1036.712 HY-D0143 HY-W009708 furyl)disulfide MedChemExpress: Nootkatone 1252.835 MedChemExpress: Magnolol 941.9616 HY-N2195 HY-N0163 Me

    Article Title: Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway.
    Article Snippet: Nootkatone was purchased from MedChemExpress (#HY-N2195).. The solid powder was dissolved with DMSO to a concentration of 458.02 mM and stored at -80 °C.The solid powder was dissolved with DMSO to a concentration of 458.02 mM and stored at -80 °C.

    Article Title: Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway
    Article Snippet: Nootkatone was purchased from MedChemExpress (#HY-N2195). .. T



    Similar Products

    nootkatone  (MedChemExpress)
    94
    MedChemExpress nootkatone
    Fig. 1 NKT inhibited the proliferation and growth of GBM cells in vitro. (A, B) The cell viability of C6 cells and U251 cells treated with gradient concentra tions (0 µM, 100 µM, 200 µM, 300 µM) of <t>nootkatone</t> detected by CCK8 assays (n = 5/group, one-way ANOVA, Tukey’s test was performed for the multiple comparison). (C, E) Cell colony formation of C6 cells and U251 cells treated with DMSO or NKT (200 µM) for approximately 7 days. Scale bar, 500 μm. (D, F) Quantitative analysis of colony number of C6 cells (D) and U251 cells (F) (the surviving colonies > 10 cells) as shown in (C, E) (n = 3/group, t-test). (G, I) Representative images of PH3 staining (red) in C6 cells and U251 cells after being treated with DMSO or 200 µM nootkatone for 48 h. Scale bars, 50 μm. (H, K) Quantitative analysis of the percentages of PH3+ cells over total C6 cells and U251 cells in one field as shown in (G, I) (n = 5/group, t-test). Data were mean ± SEM. *P < 0.05, **P < 0.01
    Nootkatone, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/hy-n2195/Nootkatone/pm39819316-28-0-4
    Average 94 stars, based on 1 article reviews
    nootkatone - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Fig. 1 NKT inhibited the proliferation and growth of GBM cells in vitro. (A, B) The cell viability of C6 cells and U251 cells treated with gradient concentra tions (0 µM, 100 µM, 200 µM, 300 µM) of nootkatone detected by CCK8 assays (n = 5/group, one-way ANOVA, Tukey’s test was performed for the multiple comparison). (C, E) Cell colony formation of C6 cells and U251 cells treated with DMSO or NKT (200 µM) for approximately 7 days. Scale bar, 500 μm. (D, F) Quantitative analysis of colony number of C6 cells (D) and U251 cells (F) (the surviving colonies > 10 cells) as shown in (C, E) (n = 3/group, t-test). (G, I) Representative images of PH3 staining (red) in C6 cells and U251 cells after being treated with DMSO or 200 µM nootkatone for 48 h. Scale bars, 50 μm. (H, K) Quantitative analysis of the percentages of PH3+ cells over total C6 cells and U251 cells in one field as shown in (G, I) (n = 5/group, t-test). Data were mean ± SEM. *P < 0.05, **P < 0.01

    Journal: Molecular medicine (Cambridge, Mass.)

    Article Title: Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway.

    doi: 10.1186/s10020-025-01064-1

    Figure Lengend Snippet: Fig. 1 NKT inhibited the proliferation and growth of GBM cells in vitro. (A, B) The cell viability of C6 cells and U251 cells treated with gradient concentra tions (0 µM, 100 µM, 200 µM, 300 µM) of nootkatone detected by CCK8 assays (n = 5/group, one-way ANOVA, Tukey’s test was performed for the multiple comparison). (C, E) Cell colony formation of C6 cells and U251 cells treated with DMSO or NKT (200 µM) for approximately 7 days. Scale bar, 500 μm. (D, F) Quantitative analysis of colony number of C6 cells (D) and U251 cells (F) (the surviving colonies > 10 cells) as shown in (C, E) (n = 3/group, t-test). (G, I) Representative images of PH3 staining (red) in C6 cells and U251 cells after being treated with DMSO or 200 µM nootkatone for 48 h. Scale bars, 50 μm. (H, K) Quantitative analysis of the percentages of PH3+ cells over total C6 cells and U251 cells in one field as shown in (G, I) (n = 5/group, t-test). Data were mean ± SEM. *P < 0.05, **P < 0.01

    Article Snippet: Nootkatone was purchased from MedChemExpress (#HY-N2195).

    Techniques: In Vitro, Comparison, Staining